Perrigo Company plc Goodwill, Foreign Currency Translation Gain (Loss)
Perrigo Company plc (PRGO) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$25.30 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-05
- Perrigo Company plc goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-27 was -$7.80M, a 107.50% decline year-over-year.
- Perrigo Company plc goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-28 was -$17.50M, a 131.14% decline year-over-year.
- Perrigo Company plc goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $6.20M.
- Perrigo Company plc goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-27 was $2.60M, a 95.45% decline year-over-year.
- Perrigo Company plc goodwill, foreign currency translation gain (loss) for fiscal 2025 was $169.00M.
- Perrigo Company plc goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$88.30M, a 283.58% decline from fiscal 2023.
- Perrigo Company plc goodwill, foreign currency translation gain (loss) for fiscal 2023 was $48.10M.
- Perrigo Company plc goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$68.50M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month as first filed | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month as first filed | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-27 | -$7.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$25.30M 10-Q · filed 2026-08-05 | -$19.10M derived: sum of 3 quarters · filed 2026-08-05 | -$16.50M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-28 | -$17.50M 10-Q · filed 2026-05-06 | -$11.30M derived: sum of 2 quarters · filed 2026-05-06 | -$8.70M derived: sum of 3 quarters · filed 2026-05-06 | $95.30M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2025-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.80M derived: sum of 2 quarters · filed 2026-02-26 | $112.80M derived: sum of 3 quarters · filed 2026-02-26 | $169.00M 10-K · filed 2026-02-26 | |||
| 2025-09-27 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $106.60M derived: sum of 2 quarters · filed 2025-11-05 | $162.80M 10-Q · filed 2025-11-05 | $61.60M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2025-06-28 | $104.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $160.20M 10-Q · filed 2025-08-06 | $59.00M derived: sum of 3 quarters · filed 2026-02-26 | $116.20M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2025-03-29 | $56.20M 10-Q · filed 2025-05-07 | -$45.00M derived: sum of 2 quarters · filed 2026-02-26 | $12.20M derived: sum of 3 quarters · filed 2026-02-26 | $4.10M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-12-31 | -$101.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$44.00M derived: sum of 2 quarters · filed 2026-02-26 | -$52.10M derived: sum of 3 quarters · filed 2026-02-26 | -$88.30M 10-K · filed 2026-02-26 | |||
| 2024-09-28 | $57.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $49.10M derived: sum of 2 quarters · filed 2024-11-06 | $12.90M 10-Q · filed 2024-11-06 | $82.30M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2024-06-29 | -$8.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$44.30M 10-Q · filed 2024-08-02 | $25.10M derived: sum of 3 quarters · filed 2025-02-28 | -$23.20M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2024-03-30 | -$36.20M 10-Q · filed 2024-05-07 | $33.20M derived: sum of 2 quarters · filed 2025-02-28 | -$15.10M derived: sum of 3 quarters · filed 2025-02-28 | -$8.30M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-12-31 | $69.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $21.10M derived: sum of 2 quarters · filed 2025-02-28 | $27.90M derived: sum of 3 quarters · filed 2025-02-28 | $48.10M 10-K · filed 2025-02-28 | |||
| 2023-09-30 | -$48.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$41.50M derived: sum of 2 quarters · filed 2023-11-07 | -$21.30M 10-Q · filed 2023-11-07 | $98.80M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2023-07-01 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $27.00M 10-Q · filed 2023-08-08 | $147.10M derived: sum of 3 quarters · filed 2024-02-27 | $59.20M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2023-04-01 | $20.20M 10-Q · filed 2023-05-09 | $140.30M derived: sum of 2 quarters · filed 2024-02-27 | $52.40M derived: sum of 3 quarters · filed 2024-02-27 | -$19.60M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-12-31 | $120.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $32.20M derived: sum of 2 quarters · filed 2024-02-27 | -$39.80M derived: sum of 3 quarters · filed 2024-02-27 | -$68.50M 10-K · filed 2024-02-27 | |||
| 2022-10-01 | -$87.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$159.90M derived: sum of 2 quarters · filed 2022-11-08 | -$188.60M 10-Q · filed 2022-11-08 | -$210.60M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2022-07-02 | -$72.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$100.70M 10-Q · filed 2022-08-09 | -$122.70M derived: sum of 3 quarters · filed 2023-02-28 | -$148.10M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2022-04-02 | -$28.70M 10-Q · filed 2022-05-11 | -$50.70M derived: sum of 2 quarters · filed 2023-02-28 | -$76.10M derived: sum of 3 quarters · filed 2023-02-28 | -$65.50M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-12-31 | -$22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$47.40M derived: sum of 2 quarters · filed 2023-02-28 | -$36.80M derived: sum of 3 quarters · filed 2023-02-28 | -$80.20M 10-K · filed 2023-02-28 | |||
| 2021-10-02 | -$25.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$14.80M derived: sum of 2 quarters · filed 2021-11-12 | -$58.20M 10-Q · filed 2021-11-12 | $3.50M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2021-07-03 | $10.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$32.80M 10-Q · filed 2021-08-11 | $28.90M derived: sum of 3 quarters · filed 2022-03-01 | $66.80M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2021-04-03 | -$43.40M 10-Q · filed 2021-05-12 | $18.30M derived: sum of 2 quarters · filed 2022-03-01 | $56.20M derived: sum of 3 quarters · filed 2022-03-01 | $68.10M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-12-31 | $61.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $99.60M derived: sum of 2 quarters · filed 2022-03-01 | $111.50M derived: sum of 3 quarters · filed 2022-03-01 | $84.80M 10-K · filed 2022-03-01 | $90.80M 10-K · filed 2021-03-01 | ||
| 2020-09-26 | $37.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $49.80M derived: sum of 2 quarters · filed 2020-11-05 | $23.10M 10-Q · filed 2020-11-05 | $62.40M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2020-06-27 | $11.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$14.80M 10-Q · filed 2020-08-05 | $24.50M derived: sum of 3 quarters · filed 2021-03-01 | -$15.30M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2020-03-28 | -$26.70M 10-Q · filed 2020-05-05 | $12.60M derived: sum of 2 quarters · filed 2021-03-01 | -$27.20M derived: sum of 3 quarters · filed 2021-03-01 | -$15.90M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-12-31 | $39.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$500.00K derived: sum of 2 quarters · filed 2021-03-01 | $10.80M derived: sum of 3 quarters · filed 2021-03-01 | -$2.80M 10-K · filed 2021-03-01 | |||
| 2019-09-28 | -$39.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$28.50M derived: sum of 2 quarters · filed 2019-11-06 | -$42.10M 10-Q · filed 2019-11-06 | -$56.50M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2019-06-29 | $11.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$2.30M 10-Q · filed 2019-08-08 | -$16.70M derived: sum of 3 quarters · filed 2020-02-27 | -$23.30M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2019-03-30 | -$13.60M 10-Q · filed 2019-05-09 | -$28.00M derived: sum of 2 quarters · filed 2020-02-27 | -$34.60M derived: sum of 3 quarters · filed 2020-02-27 | -$106.60M derived: sum of 4 quarters · filed 2020-02-27 | |||
| 2018-12-31 | -$14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$21.00M derived: sum of 2 quarters · filed 2020-02-27 | -$93.00M derived: sum of 3 quarters · filed 2020-02-27 | -$58.90M 10-K · filed 2020-02-27 | |||
| 2018-09-29 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$78.60M derived: sum of 2 quarters · filed 2018-11-08 | -$44.50M 10-Q · filed 2018-11-08 | $251.30M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2018-06-30 | -$72.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$37.90M 10-Q · filed 2018-08-09 | $257.90M derived: sum of 3 quarters · filed 2019-02-27 | $223.50M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2018-03-31 | $34.10M 10-Q · filed 2018-05-08 | $329.90M derived: sum of 2 quarters · filed 2019-02-27 | $295.50M derived: sum of 3 quarters · filed 2019-02-27 | $217.30M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-12-31 | $295.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $261.40M derived: sum of 2 quarters · filed 2019-02-27 | $183.20M derived: sum of 3 quarters · filed 2019-02-27 | $156.50M 10-K · filed 2019-02-27 | |||
| 2017-09-30 | -$34.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$112.60M derived: sum of 2 quarters · filed 2017-11-09 | -$139.30M 10-Q · filed 2017-11-09 | -$216.60M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2017-07-01 | -$78.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$104.90M 10-Q · filed 2017-08-10 | -$182.20M derived: sum of 3 quarters · filed 2018-03-01 | -$165.80M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2017-04-01 | -$26.70M 10-Q · filed 2017-05-30 | -$104.00M derived: sum of 2 quarters · filed 2018-03-01 | -$87.60M derived: sum of 3 quarters · filed 2018-03-01 | -$141.70M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-12-31 | -$77.30M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | -$60.90M derived: sum of 2 quarters · filed 2018-03-01 | -$115.00M derived: sum of 3 quarters · filed 2018-03-01 | -$26.70M 10-K · filed 2018-03-01 | $26.70M 10-K · filed 2017-05-22 | ||
| 2016-10-01 | $16.40M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-05-23 | -$37.70M derived: sum of 2 quarters · filed 2017-05-23 | $50.60M 10-Q/A · filed 2017-05-23 | -$75.10M 10-Q · filed 2016-11-10 | |||
| 2016-07-02 | -$54.10M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $34.20M 10-Q/A · filed 2017-05-22 | $56.80M 10-Q · filed 2016-08-10 | ||||
| 2016-04-02 | $88.30M 10-Q/A · filed 2017-05-22 | ||||||
| 2015-12-31 | -$58.10M 10-K · filed 2018-03-01 | ||||||
| 2015-06-27 | -$6.50M 10-K · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |